23rd annual report: Top 100 medicine highlights – PharmaLive (press release) (subscription)
23rd annual report: Top 100 medicine highlightsPharmaLive (press release) (subscription)Roche reported Rituxan/MabThera (rituximab) sales of SFr1.7 billion during first-quarter 2013, up 6 percent compared to 1Q 2012. Sales improved due to increased use…
